Sagimet Biosciences Inc. (SGMT) › Shareholders' EquitySagimet Biosciences Inc. (SGMT) — Shareholders' EquityAnnual figures by period end, from SEC filings.2021-12-31: -$158.26M2022-12-31: -$186.95M2023-12-31: $91.06M2024-12-31: $155.81M2025-12-31: $111.38M$111.38M2021-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$111.38M-28.5%2026-03-11Balance as of period end2024-12-31$155.81M+71.1%2026-03-11Balance as of period end2023-12-31$91.06M—2026-03-11Balance as of period end2022-12-31-$186.95M—2025-03-12Balance as of period end2021-12-31-$158.26M—2024-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)